Treatment of hepatitis C virus and human immunodeficiency virus co-infection

Clinical Gastroenterology and Hepatology

Volumn 3, Issue SUPPL. 2, 2005, Pages

  Sherman, Kenneth E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE DERIVATIVE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ANEMIA; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; EVALUATION; HEMOLYTIC ANEMIA; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOCHONDRIAL TOXICITY; MORTALITY; NEUTROPENIA; STANDARDIZATION;

ANTIVIRAL AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HEPATITIS C; HIV INFECTIONS; HUMANS; TREATMENT OUTCOME;

EID: 26444492155     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00704-4     Document Type: Conference Paper

References (24)

1. Update AIDS - United States, 2000 MMWR Morb Mortal Wkly Rep 51 2002 592 595
2. K.E. Sherman, S.D. Rouster, R.T. Chung Hepatitis C virus prevalence among patients infected with human immunodeficiency virus a cross-sectional analysis of the US Adult AIDS Clinical Trials Group Clin Infect Dis 34 2002 831 837
3. E.M. Tedaldi, K.H. Hullsiek, C.D. Malvestutto Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group the Terry Beirn Community Programs for Clinical Research on AIDS Clin Infect Dis 36 2003 1313 1317
4. B.H. Tess, A. Levin, G. Brubaker Seroprevalence of hepatitis C virus in the general population of northwest Tanzania Am J Trop Med Hyg 62 2000 138 141
5. T. Nemoto HIV/AIDS surveillance and prevention studies in Japan summary and recommendations AIDS Educ Prev 16 2004 27 42
6. S. Tatsunami, M. Taki, A. Shirahata Increasing incidence of critical liver disease among causes of death in Japanese hemophiliacs with HIV-1 Acta Haematol 111 2004 181 184
7. M.E. Eyster, L.S. Diamondstone, J.M. Lien Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study J Acquir Immune Defic Syndr 6 1993 602 610
8. J.J. Goedert, M.E. Eyster, M.M. Lederman End-stage liver disease in persons with hemophilia and transfusion-associated infections Blood 100 2002 1584 1589
9. Y. Benhamou, V. Di Martino, M. Bochet Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients impact of protease inhibitor therapy Hepatology 34 2001 283 287
10. N. Qurishi, C. Kreuzberg, G. Luchters Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection Lancet 362 2003 1708 1713
11. G. Greub, B. Ledergerber, M. Battegay Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection the Swiss HIV Cohort Study Lancet 356 2000 1800 1805
12. M.S. Sulkowski, R.D. Moore, S.H. Mehta Hepatitis C and progression of HIV disease JAMA 288 2002 199 206
13. R.T. Chung, S.R. Evans, Y. Yang Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects AIDS 16 2002 1915 1923
14. M.V. Ragni, F.A. Bontempo Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy J Infect Dis 180 1999 2027 2029
15. J.T. Blackard, Y. Yang, P. Bordoni Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy J Infect Dis 189 2004 1472 1481
16. K.E. Sherman Diagnosis and management of the HCV/HIV-coinfected patient AIDS Clin Care 14 2002 39 43 48
17. R.T. Chung, J. Andersen, P. Volberding Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
18. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
19. F. Carrat, F. Bani-Sadr, S. Pol Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients a randomized controlled trial JAMA 292 2004 2839 2848
20. K.E. Sherman, N.J. Shire, S.D. Rouster Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients Gastroenterology 128 2005 313 327
21. R. Fleischer, D. Boxwell, K.E. Sherman Nucleoside analogues and mitochondrial toxicity Clin Infect Dis 38 2004 e79 e80
22. L. Moreno, C. Quereda, A. Moreno Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients AIDS 18 2004 67 73
23. M. Perez-Olmeda, M. Nunez, M. Romero Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients AIDS 17 2003 1023 1028
24. M. Laguno, J. Murillas, J.L. Blanco Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients AIDS 18 2004 F27 F36